Clinicopathologic Conference, Thyrotoxic Periodic Paralysis Associated with Graves Disease
NEJM 390:1514-1522, Case 13-2024, 2024
Clinicopath Conf, Chronic Salicylate Toxicity
NEJM 388:264-272, Case Record 2, 2023
Thyrotoxic Periodic Paralysis
UptoDate Jan, Gutmann, L. & Conwit, R., 2022
Clinicopathologic Conference, Cushings syndrome due to a well-differentiated, low-grade thymic neuroendocrine tumor with corticotropin
NEJM 378:2322-2332, Case 18-2018, 2018
Clincopathologic Conference,Graves Disease with Thyrotoxic Periodic Paralysis
NEJM 366:553-560, Case 4-2012, 2012
Clinical and Functional Outcome and Factors Predicting Prognosis in Osmotic Demyelination Syndrome (Central Pontine and/or Extrapontine Myelinolysis) in 25 Patients
JNNP 82:326-331, Kallakatta,R.N.,et al, 2011
Woke Up Paralysed--Without Injury or Stroke
Lancet 371:870, Bawaskar,H.S. &Bawaskar,P.H., 2008
Osmotic Demyelination Syndrome Following Correction of Hyponatremia:Association with Hypokalemia
Am J Med 96:408-413, Lohr,J.W., 1994
Thyrotoxic Periodic Paralysis in the US, Report of 7 Cases & Review of the Literature
Medicine 71:109-120, Ober,K.P., 1992
Hyperinsulinaemia in Thyrotoxic Hypokalaemic Periodic Paralysis
Lancet 337, 1063-10641991., Lee,K.,et al, 1991
Thyrotoxic Periodic Paralysis
Arch Int Med 149:2597-2600, Kelley,D.E.,et al, 1989
Central Pontine Myelinolysis
Quart J Med 45:373, Tomlinson,B.E.,et al, 1976
The Remote Effects of Cancer on the Nervous System
Proc Roy Soc Med 60:683, Wilkinson,M., 1967